Compare ASMB & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | CHMI |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.9M | 95.5M |
| IPO Year | 2010 | N/A |
| Metric | ASMB | CHMI |
|---|---|---|
| Price | $23.17 | $2.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $44.20 | $3.00 |
| AVG Volume (30 Days) | 188.1K | ★ 219.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.09% |
| EPS Growth | ★ 91.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $638.39 | $61.13 |
| P/E Ratio | ★ N/A | $139.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.80 | $2.17 |
| 52 Week High | $39.71 | $3.04 |
| Indicator | ASMB | CHMI |
|---|---|---|
| Relative Strength Index (RSI) | 35.92 | 43.34 |
| Support Level | $20.23 | $2.25 |
| Resistance Level | $30.80 | $2.46 |
| Average True Range (ATR) | 1.51 | 0.07 |
| MACD | -0.34 | 0.00 |
| Stochastic Oscillator | 19.64 | 35.24 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.